StockData

Exicure, Inc. (XCUR) stock

XCURNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30
$1.08+0.01 (+0.93%)

Close on Nov 17, 2026Market cap $7.07MP/E –Yield –

Exicure total assets

Total assets on the balance sheet at the end of each period.

Exicure's total assets was $11.40M at Jun 30, 2026. For fiscal 2025 it was $14.04M, down 6.7% from the year before. The highest annual figure on record is $115.26M in fiscal 2019.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$14.04M-6.7%
FY2024Dec 31, 2024$15.06M+30.0%
FY2023Dec 31, 2023$11.58M-50.4%
FY2022Dec 31, 2022$23.33M-64.0%
FY2021Dec 31, 2021$64.87M-35.4%
FY2020Dec 31, 2020$100.44M-12.9%
FY2019Dec 31, 2019$115.26M+300.8%
FY2018Dec 31, 2018$28.76M-0.8%
FY2017Dec 31, 2017$28.99M+40.9%
FY2016Dec 31, 2016$20.58M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$11.40M-39.2%
Q1 FY2026Mar 31, 2026$12.76M-38.3%
Q4 FY2025Dec 31, 2025$14.04M-6.7%
Q3 FY2025Sep 30, 2025$15.27M+43.6%
Q2 FY2025Jun 30, 2025$18.74M+75.3%
Q1 FY2025Mar 31, 2025$20.68M+93.1%
Q4 FY2024Dec 31, 2024$15.06M+30.0%
Q3 FY2024Sep 30, 2024$10.63M-17.9%
Q2 FY2024Jun 30, 2024$10.69M-39.1%
Q1 FY2024Mar 31, 2024$10.71M-55.3%
Q4 FY2023Dec 31, 2023$11.58M-50.4%
Q3 FY2023Sep 30, 2023$12.95M-55.3%
Q2 FY2023Jun 30, 2023$17.56M-52.5%
Q1 FY2023Mar 31, 2023$23.94M-42.9%
Q4 FY2022Dec 31, 2022$23.33M-64.0%
Q3 FY2022Sep 30, 2022$28.94M-62.8%
Q2 FY2022Jun 30, 2022$36.96M-50.4%
Q1 FY2022Mar 31, 2022$41.90M-52.4%
Q4 FY2021Dec 31, 2021$64.87M-35.4%
Q3 FY2021Sep 30, 2021$77.90M-30.0%
Q2 FY2021Jun 30, 2021$74.47M-22.5%
Q1 FY2021Mar 31, 2021$87.95M-16.7%
Q4 FY2020Dec 31, 2020$100.44M-12.9%
Q3 FY2020Sep 30, 2020$111.28M+50.8%
Q2 FY2020Jun 30, 2020$96.12M+374.5%
Q1 FY2020Mar 31, 2020$105.53M+319.0%
Q4 FY2019Dec 31, 2019$115.26M+300.8%
Q3 FY2019Sep 30, 2019$73.81M+107.8%
Q2 FY2019Jun 30, 2019$20.26M+4.7%
Q1 FY2019Mar 31, 2019$25.18M+3.4%
Q4 FY2018Dec 31, 2018$28.76M-0.8%
Q3 FY2018Sep 30, 2018$35.53M+40.0%
Q2 FY2018Jun 30, 2018$19.34M+1251874.1%
Q1 FY2018Mar 31, 2018$24.35M+338479.2%
Q4 FY2017Dec 31, 2017$28.99M+40.9%
Q3 FY2017Sep 30, 2017$25.37M–
Q2 FY2017Aug 31, 2017$1.55K–
Q1 FY2017May 31, 2017$7.19K–
Q4 FY2016Dec 31, 2016$20.58M–

More Exicure figures

See a number that looks wrong?